EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA)

George R Thompson iD, Gelina M Sani, Monica A Donnelley, Jaimie K Figueroa, Ryan Ciuffetelli, Kate Trigg, Juan Arredondo, Alan Koff, Marie Nearing, Ikaika C Loque, Derek J Bays, Satya Dandekar

Antimicrobial Agents and Chemotherapy · 05.03.2025 · 69 (3)

DOI: 10.1128/aac.01692-24 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.03.2025. Verfasst von George R Thompson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, University of California-Davis Medical Center, Sacramento, California, USA. Hauptthemen laut MEDLINE: Amphotericin B, Complement Activation, Antifungal Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infusion reactions (tachycardia, hypertension, fever, etc.) associated with liposomal amphotericin B are common. Animal models have found complement activation responsible, yet the pathophysiology has not been evaluated in human patients. We performed a prospective observational study and found complement activation-related pseudoallergy (CARPA) responsible in those with infusion reactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BComplement ActivationAntifungal AgentsHumansProspective StudiesMaleMiddle AgedFemaleAdultAged

Stichwörter der Autor:innen

adverse drug reactionamphotericin Bhypertensionliposome

Substanzen

Amphotericin Bliposomal amphotericin BAntifungal Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Infectious Diseases, University of California-Davis Medical Center, Sacramento, California, USA.
  • Department of Medical Microbiology and Immunology, University of California-Davis, Davis, California, USA.
  • Department of Pharmacy, University of California Davis Medical Center, Sacramento, California, USA.

ORCID-Profile: George R Thompson

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health (NIH)

Zitieren

APA

Thompson, G. R., Sani, G. M., Donnelley, M. A., Figueroa, J. K., Ciuffetelli, R., Trigg, K., Arredondo, J., Koff, A., Nearing, M., Loque, I. C., Bays, D. J., & Dandekar, S. (2025). Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA). Antimicrobial Agents and Chemotherapy, 69(3). https://doi.org/10.1128/aac.01692-24

Vancouver

Thompson GR, Sani GM, Donnelley MA, Figueroa JK, Ciuffetelli R, Trigg K, et al. Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA). Antimicrobial Agents and Chemotherapy. 2025;69(3). doi:10.1128/aac.01692-24

BibTeX
@article{Thompson2025,
  author = {Thompson, George R and Sani, Gelina M and Donnelley, Monica A and Figueroa, Jaimie K and Ciuffetelli, Ryan and Trigg, Kate and Arredondo, Juan and Koff, Alan and Nearing, Marie and Loque, Ikaika C and Bays, Derek J and Dandekar, Satya},
  title = {Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA)},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {3},
  doi = {10.1128/aac.01692-24}
}
Kostenlos starten →